Successful treatment with rituximab for angioimmunoblastic T-cell lymphoma

Por Kasahara, Hidenori, Kakimoto, Tsunayuki, Saito, Hideaki, Akuta, Keigo, Yamamoto, Kazutaka, Ujiie, Hidetoshi, Sugahara, Hiroyuki, Hoshida, Yoshihiko, Sakoda, Hiroto
Publicado em 2013

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome

Por Kakimoto, Tsunayuki, Hattori, Yutaka, Okamoto, Shinichiro, Sato, Norihide, Kamata, Tamihiro, Yamaguchi, Masaya, Morita, Kunihiko, Yamada, Taketo, Takayama, Nobuyuki, Uchida, Hideo, Shimada, Naoki, Tanigawara, Yusuke, Ikeda, Yasuo
Publicado no Jpn J Cancer Res (2002)

Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity

Por Sato, Norihide, Hattori, Yutaka, Wenlin, Du, Yamada, Taketo, Kamata, Tamihiro, Kakimoto, Tsunayuki, Okamoto, Shinichiro, Kawamura, Chiharu, Kizaki, Masahiro, Shimada, Naoki, Ote, Yukiko, Hata, Jun‐ichi, Ikeda, Yasuo
Publicado no Jpn J Cancer Res (2002)